Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEOutcome of Board MeetingResults23 Jul 2026

Malu Paper Mills Limited

Outcome of Board Meeting

Malu Paper Mills Limited has submitted its un-audited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results in their meeting held on July 23, 2026.

Read more →📎 1 attachment
NSEUpdatesResults23 Jul 2026

Campus Activewear Limited

Updates

Campus Activewear Limited has informed the Exchange regarding 'Book Closure' and Annual General Meeting (AGM) details, including register of members closure from August 13-20, 2026, and e-voting facility for shareholders.

Read more →📎 1 attachment
BSECompany UpdateResults23 Jul 2026

SRF Ltd

Newspaper Publications

SRF Ltd has announced the publication of its unaudited financial results for the quarter ended June 30, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationResults23 Jul 2026

SRF Limited

Copy of Newspaper Publication

SRF Limited has informed the Exchange about the publication of un-audited financial results for the quarter ended June 30, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults23 Jul 2026

NIIT Learning Systems Limited

Press Release

NIIT Learning Systems Limited has announced its Q1 FY 2027 results, with revenue up 25% YoY to Rs. 565.1 Cr, EBITDA up 9% YoY to Rs. 103.2 Cr, and PAT up 16% YoY to Rs. 57.4 Cr. The company has also added 3 new Long Term Annuity clients and expanded the scope of one existing contract, retaining its industry-leading renewal rate.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults23 Jul 2026

Thyrocare Technologies Limited

Press Release

Thyrocare Technologies Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 24% year-on-year growth in consolidated revenue, driven by a 26% increase in the Pathology segment, and a 34% year-on-year growth in EBITDA and PAT.

Read more →📎 1 attachment
← PreviousPage 2133 of 2393Next →